ROYAL BANK OF CANADA - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 86 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$2,0000.0%6,594
+136.3%
0.00%
Q4 2016$2,0000.0%2,791
+203.4%
0.00%
Q3 2016$2,000
-66.7%
920
-48.6%
0.00%
Q2 2016$6,000
+50.0%
1,790
+79.0%
0.00%
Q1 2016$4,000
-20.0%
1,000
-8.9%
0.00%
Q4 2015$5,000
-72.2%
1,098
-62.8%
0.00%
Q3 2015$18,000
-35.7%
2,954
-7.7%
0.00%
Q2 2015$28,0003,200
+45614.3%
0.00%
Q1 2014$07
+40.0%
0.00%
Q3 2013$050.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,250,000$1,975,0001.00%
Broadfin Capital, LLC 3,567,624$5,636,0000.24%
Abingworth LLP 437,994$679,0000.19%
GREAT POINT PARTNERS LLC 250,000$395,0000.19%
Rhenman & Partners Asset Management AB 400,000$632,0000.18%
BVF INC/IL 559,624$884,0000.17%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,691,857$2,673,0000.10%
Perceptive Advisors 503,156$795,0000.07%
Gruss Capital Management LP 960,000$1,517,0000.04%
Spark Investment Management LLC 103,400$160,0000.03%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders